INS and type 1 diabetes mellitus: Comparison between young children with T1D receiving insulin degludec, insulin glargine, and NPH insulin at baseline and at end of the study (at 6 months post-therapy) showed significantly lower HbA1c in the degludec group and the glargine group at the end of the study than baseline (p = 0.001 and p = 0.024, respectively).